ArticleCancer research2014

MHC-restricted phosphopeptides from insulin receptor substrate-2 and CDC25b offer broad-based immunotherapeutic agents for cancer.

Angela L Zarling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.